Texas 2023 88th Regular

Texas Senate Bill SB2212 Introduced / Fiscal Note

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD     Austin, Texas       FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION             April 11, 2023       TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: SB2212 by Blanco (Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), As Introduced     No significant fiscal implication to the State is anticipated. Based on the analysis of the Board of Pharmacy, duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.  Local Government ImpactNo significant fiscal implication to units of local government is anticipated.  Source Agencies: b > td > 515 Board of Pharmacy  LBB Staff: b > td > JMc, NPe, SLee

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
April 11, 2023

 

 

  TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: SB2212 by Blanco (Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), As Introduced   

TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: SB2212 by Blanco (Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), As Introduced

 Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services

 Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services

 Jerry McGinty, Director, Legislative Budget Board 

 Jerry McGinty, Director, Legislative Budget Board 

 SB2212 by Blanco (Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), As Introduced 

 SB2212 by Blanco (Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), As Introduced 



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.

Based on the analysis of the Board of Pharmacy, duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.

 Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies: b > td > 515 Board of Pharmacy

515 Board of Pharmacy

LBB Staff: b > td > JMc, NPe, SLee

JMc, NPe, SLee